Speakers

Andy Bader

CSO

Triumvira Immunologics

Luise Weigand

Head of Research

Zelluna Immunotherapy

Paul Lammers

President & CEO

Triumvira Immunologics

Adam Snook

Assistant Professor

Thomas Jefferson University

Bing Wang

CEO

Refuge Biotech

Tanja Obradovic

Senior Scientific Director, Cell Therapy/ Redirected Immunity

Takeda

Dolores Schendel

CEO & CSO

Medigene

John Maher

CSO, Leucid Bio

& Senior Lecturer in Immunology Kings College London

Maurizio Chiriva- Internati

CEO & President

Kiromic Biopharma

Aiman Shalabi

VP, Medicines Development Leader, Cell and Gene Therapies

GSK

Erik Manting

CEO

Immunicum

Yuan Liu

Professor, Immunology & Cell Biology

Georgia State University

Michael Klichinsky

Co-Founder & SVP, Research

Carisma Therapeutics

Sandra Milasta

Associate Director, Immunotherapy

Elevate Bio

Saul Priceman

Assistant Professor

City of Hope

Benjamin Bengstl

Director Immunoreceptor Therapy

BioNTech

Debora Barton

CMO

Carisma Therapeutics

Robin Parihar

Assistant Professor

Baylor College of Medicine

Ahmed Ahmed

Professor of Gynaecological Oncology

University of Oxford

Erika Von Euw

Senior Director, Translational Research

T-Cure Bioscience

Hanspeter Gerber

CSO & SVP

3T Biosciences

Friedrich Graf Finckenstein

CMO

Iovance Biotherapeutics

Manish Jain

Vice President, Pharmaceutical Sciences & Manufacturing

Genocea

Namir Hassan

CEO

Zelluna Immunotherapy

Cheng Liu

Founder & CEO

Eureka Therapeutics, Inc.

Robert Weingarten

CSO

evorion biotechnologies

Will Singleterry

Commercial Director, Immuno-Oncology

LUMICKS

Alex Karlsson-Parra

CSO

Immunicum

Stanley Frankel

CMO

Cytovia Therapeutics

EVENT GUIDE